Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Carvalhas Gabrielli A"'
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 17, Pp 285-292 (2021)
Giovanni Maconi, Deborah Camatta, Rosanna Cannatelli, Francesca Ferretti, Anna Carvalhas Gabrielli, Sandro Ardizzone Gastroenterology Unit, Department of Biomedical and Clinical Sciences FBF – L.Sacco, University Hospital, Milan, ItalyCorrespondenc
Externí odkaz:
https://doaj.org/article/ebee08982e6e4a13aa4ae5fb39b5cb2a
Autor:
Maconi, Giovanni, Bosetti, Cristina, De Monti, Alberta, Boyapati, Ray Kiran, Shelton, Edward, Piazza, Nicole, Carvalhas Gabrielli, Anna Maria, Lenti, Marco Vincenzo, Bezzio, Cristina, Ricci, Chiara, Greco, Salvatore, Romeo, Samanta, Giangregorio, Francesco, Gridavilla, Daniele, Tagliani, Fabio, Massari, Alessandro, Pastorelli, Luca, Di Sabatino, Antonio, Saibeni, Simone, Alicante, Saverio, Ferretti, Francesca, Rizzardini, Giuliano, Galli, Massimo, Ardizzone, Sandro
Publikováno v:
In Digestive and Liver Disease March 2021 53(3):263-270
Autor:
Carvalhas Gabrielli, Anna Maria, Ferretti, Francesca, Monico, Camilla Maria, Tombetti, Enrico, Maconi, Giovanni, Romeo, Samanta, Piazza O Sed, Nicole, Caprioli, Flavio, Mazzola, Anna Maria, Alicante, Saverio, Bertè, Roberto, Lolli, Elisabetta, Scribano, Maria Lia, Buscarini, Elisabetta, Ricci, Chiara, Carmagnola, Stefania, Ardizzone, Sandro, Cannatelli, Rosanna
Publikováno v:
Digestive Diseases & Sciences; May2024, Vol. 69 Issue 5, p1785-1792, 8p
Autor:
Rosanna Cannatelli, Anna Maria Carvalhas Gabrielli, Deborah Camatta, Francesca Ferretti, Giovanni Maconi, Sandro Ardizzone
Publikováno v:
Therapeutics and Clinical Risk Management
Budesonide MMX is a low bioavailability corticosteroid oral once-daily formulation, which has a controlled rate of release throughout the colon, thanks to the multimatrix (MMX) formulation. It has been available for a decade in the USA and Europe for
Autor:
Maurizio Vecchi, Chiara Ricci, Francesca Ferretti, Luca Pastorelli, Claudio Camillo Cortelezzi, Giovanni Maconi, Simone Saibeni, Francesco Conforti, A. Indriolo, Sandro Ardizzone, M. Parravicini, M. Bosani, Stefania Carmagnola, Valentina Casini, Piercarlo Sarzi-Puttini, Stefano Mazza, Marco Vincenzo Lenti, Paola Cosimo, M.C. Monico, Cristina Bezzio, Andrea Cassinotti, Flavio Caprioli, Anna Maria Carvalhas Gabrielli, Antonio Di Sabatino
Publikováno v:
Journal of Gastroenterology and Hepatology
Background and Aim Since the outbreak of COVID‐19, concerns have been raised as to whether inflammatory bowel disease (IBD) patients under biologic therapy may be more susceptible to the disease. This study aimed to determine the incidence and outc
Autor:
M.C. Monico, Rosanna Cannatelli, A.M. Carvalhas Gabrielli, Stefania Carmagnola, Giovanni Maconi, Sandro Ardizzone, Francesca Ferretti
Publikováno v:
Digestive and Liver Disease
Autor:
Ardizzone, S, Ferretti, F, Monico, Mc, Carvalhas Gabrielli AM, Carmagnola, S, Bezzio, C, Bosani, M, Caprioli, F, Mazza, S, Casini, V, Cassinotti, A, Cosimo, P, Di Sabatino, A, Lenti, M, Pastorelli, L, Ricci, C, Sarzi Puttini, P, Vecchi, M5, Maconi, G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3662::d0ee224eb6ee89b9cad83cf3679be861
http://hdl.handle.net/11379/556636
http://hdl.handle.net/11379/556636
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chiara Ricci, Francesca Ferretti, Marco Vincenzo Lenti, Luca Pastorelli, Alessandro Massari, Massimo Galli, Simone Saibeni, Nicole Piazza, F. Giangregorio, Samanta Romeo, Fabio Tagliani, Ray Boyapati, Cristina Bosetti, S. Greco, Sandro Ardizzone, Alberta De Monti, Anna Maria Carvalhas Gabrielli, Giovanni Maconi, Antonio Di Sabatino, Edward Shelton, Saverio Alicante, Giuliano Rizzardini, Cristina Bezzio, Daniele Gridavilla
Publikováno v:
Digestive and Liver Disease
Background It is unclear whether patients with inflammatory bowel disease (IBD) are at increased risk of COVID-19. Objectives This observational study compared the prevalence of COVID-19 symptoms, diagnosis and hospitalization in IBD patients with a
Autor:
Massimo Galli, Luca Pastorelli, Sandro Ardizzone, Cristina Bezzio, Marco Vincenzo Lenti, Salvatore Greco, Alessandro Massari, Nicole Piazza, Fabio Tagliani, Saverio Alicante, Giuliano Rizzardini, F. Giangregorio, Simone Saibeni, Giovanni Maconi, Chiara Ricci, Alberta De Monti, Ray Kiran Boyapati, Daniele Gridavilla, Elisabetta Buscarini, Antonio Di Sabatino, Cristina Bosetti, Anna Maria Carvalhas Gabrielli, Edward Shelton
Publikováno v:
SSRN Electronic Journal.
Background & Aims: COVID-19 pandemic causes more severe illness in patients with pre-existing comorbidities and the elderly. It is unclear whether patients with chronic inflammatory disorders, such as inflammatory bowel disease (IBD), are at increase